TMO Thermo Fisher Scientific Inc

  1. Stocks
  2. Healthcare
  3. NYSE: TMO

Price (delayed)

$560.44

Market cap

$220.49B

P/E Ratio

25.76

Dividend/share

$1

EPS

$21.76

Enterprise value

$232.24B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights
TMO's EPS has soared by 134% year-on-year and by 9% since the previous quarter
Thermo Fisher Scientific's net income has soared by 132% YoY and by 8% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.thermofisher.com/
Peers: PKI BDX WAT BIO

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
393.42M
Market cap
$220.49B
Enterprise value
$232.24B
Valuations
Price to earnings (P/E)
25.76
Price to book (P/B)
5.98
Price to sales (P/S)
5.76
EV/EBIT
22.16
EV/EBITDA
17.95
EV/Sales
6.07
Earnings
Revenue
$38.25B
EBIT
$10.48B
EBITDA
$12.94B
Free cash flow
$8.14B
Per share
EPS
$21.76
Free cash flow per share
$20.71
Book value per share
$93.77
Revenue per share
$97.33
TBVPS
$72.27
Balance sheet
Total assets
$67.7B
Total liabilities
$30.84B
Debt
$18.78B
Equity
$36.85B
Working capital
$12.34B
Liquidity
Debt to equity
0.51
Current ratio
2.78
Quick ratio
1.8
Net debt/EBITDA
0.91
Margins
EBITDA margin
33.8%
Gross margin
51.3%
Net margin
22.5%
Operating margin
28%
Efficiency
Return on assets
12.9%
Return on equity
24.9%
Return on invested capital
32.3%
Return on capital employed
17.2%
Return on sales
27.4%
Dividend
Dividend yield
0.18%
DPS
$1
Payout ratio
4.6%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
-0.45%
1 week
-1.47%
1 month
1.08%
1 year
29.17%
YTD
20.32%
QTD
11.09%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$38.25B
Gross profit
$19.62B
Operating income
$10.71B
Net income
$8.6B
Gross margin
51.3%
Net margin
22.5%
The operating income has soared by 139% YoY and by 8% from the previous quarter
Thermo Fisher Scientific's net income has soared by 132% YoY and by 8% from the previous quarter
Thermo Fisher Scientific's operating margin has soared by 65% YoY
Thermo Fisher Scientific's gross profit has soared by 65% YoY and by 6% from the previous quarter

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
P/E
25.76
P/B
5.98
P/S
5.76
EV/EBIT
22.16
EV/EBITDA
17.95
EV/Sales
6.07
TMO's EPS has soared by 134% year-on-year and by 9% since the previous quarter
The stock's price to earnings (P/E) is 19% less than its 5-year quarterly average of 31.7 and 6% less than its last 4 quarters average of 27.4
The P/B is 57% above the 5-year quarterly average of 3.8 and 13% above the last 4 quarters average of 5.3
The company's equity rose by 23% YoY and by 5% QoQ
Thermo Fisher Scientific's revenue has increased by 46% YoY and by 7% from the previous quarter
The P/S is 34% above the 5-year quarterly average of 4.3 and 4.7% above the last 4 quarters average of 5.5

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's return on invested capital has surged by 111% year-on-year and by 7% since the previous quarter
TMO's ROA has soared by 105% YoY and by 6% from the previous quarter
The ROE has soared by 98% YoY and by 3.3% from the previous quarter
TMO's ROS has soared by 59% year-on-year

Dividends

What is TMO's dividend history
DPS
$1
Dividend yield
0.18%
Payout ratio
4.6%
Recent dividends

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 119% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has increased by 13% from the previous quarter and by 5% YoY
The current ratio has increased by 10% since the previous quarter and by 6% year-on-year
The debt is 49% lower than the equity
Thermo Fisher Scientific's debt to equity has decreased by 28% YoY and by 3.8% QoQ
The company's equity rose by 23% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.